ZyVersa Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative therapies for a variety of medical conditions, particularly those associated with inflammation and metabolic diseases
The company aims to address unmet medical needs through its research and development of novel drug candidates that target key biological pathways. By leveraging its proprietary technologies, ZyVersa is engaged in advancing therapies that not only have the potential to improve patient outcomes but also enhance the overall quality of life for individuals suffering from chronic ailments.
ZyVersa Therapeutics shares are trading higher Monday after the company announced the publication of a scientific paper in a peer-reviewed journal that reinforces the rationale for inhibiting ASC with IC 100 to potentially attenuate cardiac comorbidities in patients with Alzheimer's Disease.
The 2024 Benzinga Virtual Healthcare Summit brings together top healthcare professionals and companies to discuss industry trends, advancements in technology, and the future of healthcare. Don't miss out on this must-attend event!
Shares of TransMedics Group, Inc. (NASDAQTMDX) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued strong guidance.
U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining around 50 points on Monday. Following the market opening Monday, the Dow traded up 0.04% 39,148.74 while the NASDAQ rose 0.36% to 16,054.82. The S&P 500 also rose, gaining, 0.16% to 5,096.91.
Shares of Intuitive Machines, Inc. (NASDAQLUNR) fell sharply in today’s pre-market trading. Intuitive Machines revealed Friday that its lunar lander, Odysseus, encountered a mishap during a touchdown near the moon’s south pole.
